Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study

This study observed the antibody response and adverse events of AZD1222 (Oxford/AstraZeneca) vaccination in dialysis patients. A prospective cohort study was conducted in E-Da Healthcare Group hospitals between 1 July and 30 November 2021. Patients receiving hemodialysis (HD, <i>n</i> = 204) or peri...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hsi-Hao Wang, Jia-Ling Wu, Min-Yu Chang, Hsin-Mian Wu, Li-Chun Ho, Po-Jui Chi, Ching-Fang Wu, Wan-Chia Lee, Hung-Hsiang Liou, Shih-Yuan Hung, Yi-Che Lee
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-09-01
Col·lecció:	Vaccines
Matèries:	COVID-19 vaccination AZD1222 antibody response adverse events dialysis
Accés en línia:	https://www.mdpi.com/2076-393X/10/9/1460
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!